MedTrace Logo

MIRODERM™ for Complex Wounds in an Inpatient Setting (MIRODERM CLOSure)

NCT02732548 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2017-07-19

No results posted yet for this study

Summary

This study is being conducted to collect data on the performance of Miromatrix Wound Matrix (MIRODERM) when used in the treatment of complex wounds in an inpatient setting.

Conditions

  • Complex Wound

Interventions

OTHER

Negative Pressure Wound Therapy (NPWT)

OTHER

MIRODERM Application(s)

OTHER

Standard Care

wound measurement, debridement, photography of wound, moist wound environment, infection management, nutritional support

Sponsors & Collaborators

  • Miromatrix Medical Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2016-12-31
Completion
2017-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02732548 on ClinicalTrials.gov